Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Recommendation of "Hold" from Analysts

Key Points

• Pediatrix Medical Group has received a consensus rating of "Hold" from analysts, with four hold recommendations and two buy recommendations.
• The company's average twelve-month price target among brokerages is currently $16.67, reflecting recent stock price fluctuations.
• Pediatrix Medical Group reported earnings of $0.53 per share, exceeding expectations, but noted a year-over-year revenue decline of 7.1%.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has received an average rating of "Hold" from the six analysts that are currently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $16.6667.

Several research firms recently weighed in on MD. Macquarie raised their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. UBS Group reissued a "neutral" rating on shares of Pediatrix Medical Group in a research note on Thursday.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its holdings in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares in the last quarter. Marshall & Sullivan Inc. WA acquired a new stake in shares of Pediatrix Medical Group during the second quarter worth $41,000. AlphaQuest LLC lifted its holdings in shares of Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock worth $85,000 after buying an additional 811 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after buying an additional 5,104 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in shares of Pediatrix Medical Group during the second quarter worth $99,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 0.3%

Shares of MD traded up $0.05 during mid-day trading on Thursday, hitting $15.55. 66,826 shares of the company's stock were exchanged, compared to its average volume of 746,738. The company has a market cap of $1.35 billion, a PE ratio of 12.02 and a beta of 1.21. Pediatrix Medical Group has a 52 week low of $10.02 and a 52 week high of $17.67. The company has a 50-day simple moving average of $13.47 and a 200 day simple moving average of $13.84. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. During the same period last year, the business earned $0.34 earnings per share. The firm's revenue was down 7.1% on a year-over-year basis. On average, research analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.